Dosage forms of apixaban

Details for Australian Patent Application No. 2010260208 (hide)

Owner Pfizer Inc. Bristol-Myers Squibb Company

Inventors Nause, Richard G.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010260208

PCT Pub. Number WO2010/147978

Priority 61/187,442 16.06.09 US

Filing date 15 June 2010

Wipo publication date 23 December 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/437 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

15 December 2011 PCT application entered the National Phase

  PCT publication WO2010/147978 Priority application(s): WO2010/147978

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010260211-Safe desmopressin administration

2010260200-Suspended media membrane biological reactor system and process including multiple biological reactor zones